Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for October 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Switching From IV to Oral Meds Cuts Health Care Costs
MONDAY, Oct. 31 (HealthDay News) -- For patients who are clinically eligible for oral (PO) medication intake, switching from intravenous (IV) to oral medication can substantially reduce the annual cost of health care, according to a study published online Oct. 17 in Clinical Therapeutics.
Study Finds Statins Don't Slow Atherosclerosis in Pediatric SLE
THURSDAY, Oct. 27 (HealthDay News) -- Atorvastatin therapy for three years has no significant effect on atherosclerosis progression, as measured by mean-mean common carotid intima-media thickening (CIMT), in a pediatric population with systemic lupus erythematosus (SLE), according to a study published online Oct. 26 in Arthritis & Rheumatism.
Briakinumab More Effective Than Methotrexate in Psoriasis
THURSDAY, Oct. 27 (HealthDay News) -- For patients with moderate to severe psoriasis, briakinumab is more effective than methotrexate, although serious infections and cancers occur more frequently with briakinumab, according to a study published in the Oct. 27 issue of the New England Journal of Medicine.
Ghost Authorship Prevalent in About One-Fifth of Articles
WEDNESDAY, Oct. 26 (HealthDay News) -- The prevalence of articles with honorary authorship, ghost authorship, or both is 21 percent, which marks a significant decrease since 1996, according to a study published online Oct. 25 in BMJ.
Radiographic Osteoarthritis Phenotypes Linked to Race
TUESDAY, Oct. 25 (HealthDay News) -- African-Americans are less likely to have hand radiographic osteoarthritis (rOA) phenotypes, but are more likely to have knee rOA phenotypes involving the tibiofemoral joints (TFJ), according to a study published online Oct. 20 in Arthritis & Rheumatism.
Early Impact of RA on Women's Daily Activities, Occupation
FRIDAY, Oct. 21 (HealthDay News) -- For women with rheumatoid arthritis (RA), daily activities and occupational identity are affected in the first 12 months after diagnosis, according to a study published online Oct. 17 in Arthritis Care & Research.
Ultrasound, Shock Wave Not Effective for Low Back Pain
FRIDAY, Oct. 21 (HealthDay News) -- The available evidence does not support the effectiveness of ultrasound or shock wave for treating low back pain (LBP), according to a review published in the October issue of The Spine Journal.
Trabecular Bone Texture Predicts Arthritis Progression
FRIDAY, Oct. 21 (HealthDay News) -- Automated analysis of tibial trabecular bone (TB) texture in individuals with or without radiographic knee osteoarthritis shows promise for predicting progressive tibiofemoral joint space loss, according to a study published online Oct. 11 in Arthritis & Rheumatism.
Readmission Risk Models Display Poor Predictive Ability
TUESDAY, Oct. 18 (HealthDay News) -- Most hospital readmission risk models have poor predictive ability, according to a review published in the Oct. 19 issue of the Journal of the American Medical Association.
Rare Disorders ID'd by NIH Undiagnosed Diseases Program
THURSDAY, Oct. 13 (HealthDay News) -- The extensive application of genomic technology under the U.S. National Institutes of Health Undiagnosed Diseases Program (NIH-UDP) helps diagnose complex and rare multisystem disorders, according to a report published online Sept. 26 in Genetics in Medicine.
Financial Conflicts of Interest Prevalent, Under-Reported
WEDNESDAY, Oct. 12 (HealthDay News) -- Conflicts of interest (COI) are prevalent among members and chairs of guideline panels, and are under-reported, according to a study published online Oct. 11 in BMJ.
'Timed Up and Go' Test Predicts Nonvertebral, Hip Fractures
WEDNESDAY, Oct. 12 (HealthDay News) -- "Timed up and go" (TUG) test performance is an independent predictor of risk for incident nonvertebral and hip fractures in elderly women, according to a study published in the Oct. 10 issue of the Archives of Internal Medicine.
ERα Autoantibodies Affect Disease Activity in Lupus
TUESDAY, Oct. 11 (HealthDay News) -- In patients with systemic lupus erythematosus (SLE), autoantibodies specific to estrogen receptor α (anti-ERα Abs) interfere with T lymphocyte homeostasis and are significantly associated with disease activity, according to a study published online Oct. 3 in Arthritis & Rheumatism.
Septicemia Most Costly Reason for Hospitalization in 2009
MONDAY, Oct. 10 (HealthDay News) -- Septicemia was the single most expensive condition treated in U.S. hospitals in 2009, with expenditure totaling nearly $15.4 billion, according to an October statistical brief based on Healthcare Cost and Utilization Project (HCUP) data published by the Agency for Healthcare Research and Quality (AHRQ).
Anti-TNF-α Use Cuts Diabetes Risk in Rheumatoid Arthritis
FRIDAY, Oct. 7 (HealthDay News) -- Patients with rheumatoid arthritis (RA) who are treated with anti-tumor necrosis factor-α (TNF-α) therapy have a reduced risk of developing diabetes, according to a study published online Oct. 3 in Arthritis Care & Research.
Use of Oral Steroids Linked to Vitamin D Deficiency
THURSDAY, Oct. 6 (HealthDay News) -- The use of oral steroids is associated with serum 25-hydroxyvitamin D (25[OH]D) deficiency, according to a study published online Sept. 28 in the Journal of Clinical Endocrinology & Metabolism.
More Minority Patients in Low-Quality, High-Cost Hospitals
THURSDAY, Oct. 6 (HealthDay News) -- Hospitals where the quality is low and costs high (worst hospitals) in the United States care for a higher proportion of elderly black, Hispanic, and Medicaid patients than high-quality, low-cost institutions (best hospitals), according to a study published in the October issue of Health Affairs.
Poor Footwear Ups Impairment, Disability in Chronic Gout
MONDAY, Oct. 3 (HealthDay News) -- Use of poor footwear is common among patients with chronic gout, and is associated with foot-related disability and impairment, according to a study published online Oct. 3 in Arthritis Care & Research.
Vitamin D Insufficiency Prevalent in Psoriatic Arthritis
MONDAY, Oct. 3 (HealthDay News) -- Vitamin D insufficiency appears to be highly prevalent among people with psoriatic arthritis (PsA), regardless of where they live or the time of year, according to research published in the October issue of Arthritis Care & Research.
Copyright © 2011 ScoutNews, LLC. All rights reserved.
|Previous: October 2011 Briefing - Pulmonology||Next: October 2011 Briefing - Surgery|
Reader comments on this article are listed below. Review our comments policy.